Increased platelet activation markers in rheumatoid arthritis: Are they related with subclinical atherosclerosis?

Platelets

Volumn 19, Issue 2, 2008, Pages 146-154

  Pamuk, Gülsüm Emel ^a,b   Vural, Özden ^a   Turgut, Burhan ^a   Demir, Muzaffer ^a   Pamuk, Ömer Nuri ^a   Çakir, Necati ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

CD40 ligand; CD62P; Inflammation; Platelet monocyte complex; Platelet neutrophil complex; Rheumatoid arthritis

Indexed keywords

CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEX RATIO; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION;

ANTITHROMBINS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD COAGULATION; CAROTID ARTERIES; CD40 LIGAND; E-SELECTIN; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; P-SELECTIN; PLATELET ACTIVATION; THROMBIN; TUNICA INTIMA;

EID: 39749193487     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701210057     Document Type: Article

References (42)

1. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862-873.
2. Kaplan MJ, McCune WJ. New evidence for vascular disease in patients with early rheumatoid arthritis. Lancet 2003;361:1068-1069.
3. De Maat MPM, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: Results of the Glostrup study. J Thomb Haemost 2003;1:950-957.
4. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby A, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000;321:199-204.
5. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.
6. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 2003;42:292-297.
7. Andre P. P-selectin in haemostasis. Br J Haematol 2004;126:298-306.
8. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97:13835-13840.
9. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004;125:777-787.
10. Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 2001;104:197-205.
11. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002;46:1498-1503.
12. Villmow T, Kemkes-Matthes B, Matzdorff AC. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Research 2002;108:139-145.
13. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-646.
14. Silverstein RL, Nachman RL. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest 1987;79:867-874.
15. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31:352-358.
16. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-1111.
17. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004;14:18-22.
18. Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003;1:1699-1709.
19. Egerer K, Hertzer J, Feist E, Albrecht A, Rudolph PE, Dorner T, Burmester GR. sE-selectin for stratifying outcome in rheumatoid arthritis. Arthritis Rheum 2003;49:546-548.
20. Jonsson SW, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Dahlqvist SR. Increased prevalance of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001;28:2597-2602.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra SR. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
22. Vitali C, Bombardieri S, Moutsopoulos AM, Coll J, Gerli R, Hatron PY, Kater L, Konttinen YT, Manthorpe R, Meyer O, Mosca M, Ostuni P, Pellerito RA, Pennec Y, Porter SR, Richards A, Sauvezie B, Schiodt M, Sciuto M, Shoenfeld Y, Skopouli FN, Smolen JS, Soromenho F, Tishler M, Wattiaux MJ. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996;55:116-121.
23. Prevoo MLL, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-48.
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
25. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leukocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451-459.
26. Krueger LA, Barnard MR, Frelinger AL III, Furman MI, Michelson AD. Immunophenotypic analysis of platelets, In: Robinson JP, Darzynkiewicz Z, Dean PN, Dresiler LG, Rabinovitch PS, Stewart CC, Tanke HJ, Wheeless MC, editors. Current protocols in cytometry. New York: John Wiley & Sons Inc; 2002, pp 6.10.1-6.10.17.
27. Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade C-reactive protein elevation correlated with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005;32:1219-1223.
28. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Poruua C, Gonzalez-Gay MA. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine 2003;82:407-413.
29. Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 1997;36:164-169.
30. Ertenli I, Kiraz S, Arici M, Haznedaroglu IC, Calguneri M, Celik I, Kirazli S. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol 1998;25:1054-1058.
31. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001;85:810-820.
32. Distler JHW, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005;52:3337-3348.
33. 2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: Interaction with platelets. J Rheumatol 2004;31:2347-2355.
34. Kyburz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 1999;163:3116-3222.
35. Berner B, Wolf G, Hummel KM, Muller GA, Reuss-Borst MA. Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis 2000;59:190-195.
36. Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, Kuriyama M, Kipps TJ, Hashimoto H. Soluble CD154 in rheumatoid arthritis: Elevated plasma levels in cases with vasculitis. J Rheumatol 2001;28:2583-2590.
37. Oxholm P, Winther K, Manthorpe R. Platelets in blood and salivary glands of patients with primary Sjogren's syndrome. Scand J Rheumatol Suppl 1986;61:170-172.
38. Torsteinsdottir I, Gudbjornsson B, Hakansson L. Enhanced neutrophil and eosinophil adhesion in patients with primary sjögren's syndrome. Clin Exp Rheumatol 1998;16:255-262.
39. Cobankara V, Ozatli D, Kiraz S, Ozturk MA, Ertenli I, Turk T, Apras S, Haznedaroglu IC, Calguneri M. Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level. Clin Rheumatol 2004;23:430-434.
40. Firestein GS. Rheumatoid synovitis and pannus, In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed., Vol. 1. Edinburgh: Elsevier Limited; 2003, pp 855-884.
41. Gallistl S, Mangge H, Neuwirth G, Muntean W. Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res 1998;92:267-272.
42. Gabazza EC, Osamu T, Yamakami T, Ibata H, Sato T, Shima T. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis. Thromb Haemost 1994;71:199-202.